| Document Date: 2013-02-14 16:20:44
Open Document File Size: 1,23 MBShare Result on Facebook
City Reference / / Currency pence / / Facility Laboratory Abnormality / Appropriate laboratory / Laboratory Abnormalities Reported / / IndustryTerm treatment of HIV / food / / MedicalCondition Abdominal pain / Autoimmune disorders / pneumonia / hemolytic anemia / hypertension / hemophilia A / HIV / opportunistic infections / disease / headache / myopathy / Sulfa Allergy / Carcinogenesis / hyperglycemia / cardiac arrhythmias / Diabetes/Hyperglycemia / neutropenia / nausea / Skin Rash / Diabetes / hepatitis B / Allergy / Stevens-Johnson syndrome / rhabdomyolysis / syncope / vomiting / Fatigue / pulmonary / diabetes mellitus / diabetic ketoacidosis / obesity / Hypersensitivity / diarrhea / respiratory depression / infection / pruritus / rash / Nephrolithiasis / Hemophilia / Anemia / Syndrome / inflammatory / polymyositis / tuberculosis / immune reconstitution syndrome / hypotension / sulfonamide allergy / / MedicalTreatment antiretroviral treatment / antiretroviral therapy / / Organization DOSAGE AND ADMINISTRATION / FDA / Once-daily administration / / / Position General / / Product LEXIVA / simvastatin / abacavir / lamivudine / triazolam / Oral Suspension / Rifampin / Lovastatin / REVATIO / / Technology Alpha / Pharmacokinetics / / URL www.fda.gov/medwatch / /
SocialTag |
----------------------- WARNINGS AND PRECAUTIONS ---------------• Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1) • LEXIVA should be discon